Clinical trial

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

NCT02849457

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-01

PhasePHASE2

Study timeline

Study start (unknown)2016-12-01Date precision: month

Registry last updated2024-08-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberous Sclerosis Complexunresolved

Interventions

Early VigabatrinDRUG

Delayed Vigabatrin (Placebo)DRUG

Sponsors & collaborators

Martina Bebinlead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Mapped research locations

HoustonTexas, United States1 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 St LouisMissouri, United States1 SeattleWashington, United States1 BirminghamAlabama, United States1 CincinnatiOhio, United States1 DurhamNorth Carolina, United States1 Washington D.C.District of Columbia, United States1 Palo AltoCalifornia, United States1 Saint PaulMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02849457 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.